Literature DB >> 20981450

Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants.

Radhika Sampat1, Rong Fu, Laura E Larovere, Rosa J Torres, Irene Ceballos-Picot, Michel Fischbach, Raquel de Kremer, David J Schretlen, Juan Garcia Puig, H A Jinnah.   

Abstract

Lesch-Nyhan disease is a neurogenetic disorder caused by mutation of the HPRT1 gene on the X chromosome. There is significant variation in the clinical phenotype, with more than 300 different known mutations. There are few studies that have addressed whether similar mutations result in similar phenotypes across different patients because hypoxanthine-guanine phosphoribosyltransferase (HGprt) deficiency is rare, and most mutations are unique or limited to individual families. However, recent studies have revealed multiple unrelated patients with similar mutations, providing an opportunity to examine genotype-phenotype correlations. We found significant variation among the clinical features of 10 patients from 8 unrelated families all carrying a mutation replacing guanine with adenine at base position 143 (c.143G>A) in the HPRT1 gene. This mutation results in replacement of arginine by histidine at amino acid position 48 (p.arg48his) in the HGprt enzyme. Biochemically, the enzyme exhibits reduced thermal integrity, a mechanism that may explain clinical variation. The literature reveals similar clinical variation among other patients with similar mutations, although the variation is relatively minor across the whole population of patients. Identifiable sources of clinical variation include known limitations of clinical ascertainment and mechanisms that affect residual enzyme activity and stability. These results are helpful for understanding genotype-phenotype correlations and discordance and likely are applicable to other neurogenetic disorders where similar variation occurs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981450      PMCID: PMC3034646          DOI: 10.1007/s00439-010-0901-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  33 in total

1.  Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations.

Authors:  E Zoref-Shani; S Feinstein; Y Frishberg; Y Bromberg; O Sperling
Journal:  Biochim Biophys Acta       Date:  2000-02-21

2.  Hypoxanthine phosphoribosyltransferase activity in intact fibroblasts from patients with X-linked hyperuricemia.

Authors:  M J Holland; A M DiLorenzo; J Dancis; M E Balis; T F Yü; R P Cox
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

3.  The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families.

Authors:  J G Puig; R J Torres; F A Mateos; T H Ramos; J M Arcas; A S Buño; P O'Neill
Journal:  Medicine (Baltimore)       Date:  2001-03       Impact factor: 1.889

4.  Lesch-Nyhan syndrome: absence of the mutant enzyme in erythrocytes of a heterozygote for both normal and mutant hypoxanthine-guanine phosphoribosyl transferase.

Authors:  J A McDonald; W N Kelley
Journal:  Biochem Genet       Date:  1972-02       Impact factor: 1.890

5.  The spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  B T Emmerson; L Thompson
Journal:  Q J Med       Date:  1973-04

Review 6.  The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases.

Authors:  H A Jinnah; L De Gregorio; J C Harris; W L Nyhan; J P O'Neill
Journal:  Mutat Res       Date:  2000-10       Impact factor: 2.433

7.  Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis.

Authors:  J E Seegmiller; F M Rosenbloom; W N Kelley
Journal:  Science       Date:  1967-03-31       Impact factor: 47.728

8.  Structural and functional analysis of mutations at the human hypoxanthine phosphoribosyl transferase (HPRT1) locus.

Authors:  Jianxin Duan; Lennart Nilsson; Bo Lambert
Journal:  Hum Mutat       Date:  2004-06       Impact factor: 4.878

9.  Disparate enzyme activity in erythocytes and leukocytes. A variant of hypoxanthine phosphoribosyl-transferase deficiency with an unstable enzyme.

Authors:  J Dancis; L C Yip; R P Cox; S Piomelli; M E Balis
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

10.  Kelley-Seegmiller syndrome in a patient with complete hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  A Cossu; V Micheli; G Jacomelli; A Carcassi
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

View more
  9 in total

Review 1.  Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.

Authors:  Noha F Minshawi; Sarah Hurwitz; Danielle Morriss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2015-06

2.  Genotype-phenotype correlations in Lesch-Nyhan disease: moving beyond the gene.

Authors:  Rong Fu; H A Jinnah
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

3.  Phenotypic variation among seven members of one family with deficiency of hypoxanthine-guanine phosphoribosyltransferase.

Authors:  Irène Ceballos-Picot; Franck Augé; Rong Fu; Anne Olivier-Bandini; Julie Cahu; Brigitte Chabrol; Bernard Aral; Bérengère de Martinville; Jean-Paul Lecain; H A Jinnah
Journal:  Mol Genet Metab       Date:  2013-09-08       Impact factor: 4.797

4.  Late diagnosis of Lesch-Nyhan disease variant.

Authors:  Brian Percy Doucet; Dev Jegatheesan; John Burke
Journal:  BMJ Case Rep       Date:  2013-12-10

5.  Transcriptomic approach to Lesch-Nyhan disease.

Authors:  Luce Dauphinot; Lionel Mockel; Julie Cahu; H A Jinnah; Morgan Ledroit; Marie-Claude Potier; Irène Ceballos-Picot
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2014       Impact factor: 1.381

Review 6.  Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder.

Authors:  Rong Fu; Irene Ceballos-Picot; Rosa J Torres; Laura E Larovere; Yasukazu Yamada; Khue V Nguyen; Madhuri Hegde; Jasper E Visser; David J Schretlen; William L Nyhan; Juan G Puig; Patrick J O'Neill; H A Jinnah
Journal:  Brain       Date:  2013-08-22       Impact factor: 13.501

Review 7.  Nucleotide salvage deficiencies, DNA damage and neurodegeneration.

Authors:  Michael Fasullo; Lauren Endres
Journal:  Int J Mol Sci       Date:  2015-04-27       Impact factor: 5.923

Review 8.  The genetic framework for development of nephrolithiasis.

Authors:  Vinaya Vasudevan; Patrick Samson; Arthur D Smith; Zeph Okeke
Journal:  Asian J Urol       Date:  2016-11-28

9.  The Study on the Clinical Phenotype and Function of HPRT1 Gene.

Authors:  Miao Guo; Yucai Chen; Longlong Lin; Yilin Wang; Anqi Wang; Fang Yuan; Chunmei Wang; Simei Wang; Yuanfeng Zhang
Journal:  Child Neurol Open       Date:  2022-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.